Investors may be wondering whether Natera's current share price reflects its potential, or if the stock is starting to look stretched. Natera recently closed at US$182.65, with a 7 day return of an 8.

Stanley Druckenmiller is a legendary Wall Street investor, and there are very few investors on Wall Street with such an ...

The bayfront property that was home for more than eight decades to the horse racing track Golden Gate Fields could be ...

A new study shows Signatera ctDNA testing may identify older patients with ER+/HER2- breast cancer who can manage their care ...

Natera Inc. NTRA shares are up on Tuesday as the company announced promising results from a prospective study regarding its ...

A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced a publication in ...

Myriad Genetics has grown from a mainly Hereditary Cancer business into a broader precision medicine company. Click here to ...

A Relative Strength Rating upgrade for Natera shows improving technical performance. Will it continue?

The Virtus Zevenbergen Innovative Growth Stock Fund returned -2.74% (Class I) in the quarter, trailing the Russell 3000 Growth Index's 1.14% return. Read more here.

ARK Invest sold over $87M in Nvidia and Meta shares last week while purchasing Circle Internet and CoreWeave in a strategic ...

A large observational analysis suggests that the presence of isolated tumor cells may signal worse survival in low-risk endometrial cancer.